Industries > Pharma > eClinical Solutions Market Report 2023-2033

eClinical Solutions Market Report 2023-2033

Forecasts by Product Type (Clinical Trial Management Systems (CTMS), Clinical Data Management Systems (CDMS), Randomisation and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient-reported Outcomes (ePRO), Clinical Data Integration Platform (CDIP), Electronic Data Capture (EDC), Safety Solutions, Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Others)), by Deployment Type (Cloud-based (SAAS) Solutions, Web-hosted (On-demand) Solutions, Licensed Enterprise (On-premises) Solutions)), by End-users (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organisations, Consulting Service Companies, Hospitals and Clinics, Medical Device Manufacturers, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 17 March 2023
PAGES: 254
PRODUCT CODE: PHA1240
SUBMARKET: Digital Healthcare

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The eClinical solutions Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Adoption of Electronic Data Capture (EDC) Systems in Clinical Trials to Spur Industry Growth
The market for eClinical solutions is expanding significantly as a result of the increased use of electronic data capture (EDC) systems in clinical trials. EDC systems have a number of advantages over conventional paper-based data collection techniques, including:
• Increased accuracy and efficiency
• Improved data quality
• Enhanced patient safety
• Enhanced data management
• Cost savings

Companies using EDC systems in clinical trials include Pfizer, AstraZeneca, and Novartis. These companies have reported increased efficiency and data quality, as well as improved patient safety and cost savings, as a result of their use of EDC systems.

High Installation Costs Likely to Challenge Industry Growth
One of the main factors limiting the growth of the eClinical solutions market is the high installation cost. The implementation of eClinical solutions typically requires a significant investment in hardware, software, and personnel, which can be a challenge for some organisations, particularly those with limited budgets.

In addition to the upfront costs, the ongoing maintenance and support costs for eClinical solutions can also be high, as organisations must continuously invest in technology upgrades, security measures, and other infrastructure improvements.

Despite these challenges, many organisations are choosing to invest in eClinical solutions due to the numerous benefits they provide, including improved data accuracy, increased efficiency, and compliance with regulatory requirements.

What Questions Should You Ask before Buying a Market Research Report?
• How is the eClinical solutions market evolving?
• What is driving and restraining the eClinical solutions market?
• How will each eClinical solutions submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each eClinical solutions submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading eClinical solutions markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2033? What are the implications of eClinical solutions projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the eClinical solutions market?
• Where is the eClinical solutions market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the eClinical solutions market today, and over the next 10 years:
• Our 254-page report provides 97 tables and 147 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the eClinical solutions market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising eClinical solutions prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product Type
• Clinical Trial Management Systems (CTMS)
• Clinical Data Management Systems (CDMS)
• Randomisation and Trial Supply Management (RTSM)
• Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient-reported Outcomes (ePRO)
• Clinical Data Integration Platform (CDIP)
• Electronic Data Capture (EDC)
• Safety Solutions
• Clinical Analytics Platforms
• Electronic Trial Master File (eTMF)
• Others

Deployment Type
• Cloud-based (SAAS) Solutions
• Web-hosted (On-demand) Solutions
• Licensed Enterprise (On-premises) Solutions

End-users
• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organisations
• Consulting Service Companies
• Medical Device Manufacturers
• Hospitals and Clinics
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

eClinical Solutions Market 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the eClinical solutions Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Clario
• Dassault Systèmes
• eClinical Solutions LLC
• IBM
• IQVIA Inc.
• Medrio, Inc.
• Oracle
• Parexel International Corporation
• Signant Health
• Veeva Systems

Overall world revenue for eClinical solutions market, 2023 to 2033 in terms of value the market will surpass US$8.9 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the eClinical solutions market, 2023 to 2033 report help you?
In summary, our 250+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for eClinical solutions market, 2023 to 2033 Market, with forecasts for product type, deployment type, and end users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the eClinical solutions Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the eClinical solutions Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the eClinical solutions market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today eClinical Solutions Market Report 2023-2033: Forecasts by Product Type (Clinical Trial Management Systems (CTMS), Clinical Data Management Systems (CDMS), Randomisation and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient-reported Outcomes (ePRO), Clinical Data Integration Platform (CDIP), Electronic Data Capture (EDC), Safety Solutions, Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Others), by Deployment Type (Cloud-based (SAAS) Solutions, Web-hosted (On-demand) Solutions, Licensed Enterprise (On-premises) Solutions), by End-users (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organisations, Consulting Service Companies, Hospitals and Clinics, Medical Device Manufacturers, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for eClinical Solutions Market Report 2023-2033

    Download sample pages

    Complete the form below to download your free sample pages for eClinical Solutions Market Report 2023-2033

      Latest Pharma news

      Visiongain Publishes Pharma Wholesale and Distribution Market Report 2024-2034

      The global Pharma Wholesale and Distribution market is estimated at US$844.2 billion in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.

      20 February 2024

      READ

      Visiongain Publishes Biobanking Market Report 2024-2034

      The global Biobanking market is estimated at US$75.4 billion in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period 2024-2034.

      19 February 2024

      READ

      Visiongain Publishes Dermatological Drugs Market Report 2024-2034

      The Dermatological Drugs market is estimated at US$30.47 billion in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period 2024-2034.

      13 February 2024

      READ

      Visiongain Publishes Allergic Rhinitis Drugs Market Report 2024-2034

      The global Allergic Rhinitis Drugs market is estimated at US$16,821.6 million in 2024 and is expected to register a CAGR of 2.7% from 2024 to 2034.

      12 February 2024

      READ